Jacobio Pharmaceuticals (1167) Announces Board Meeting for Annual Results

Bulletin Express
02/26

Jacobio Pharmaceuticals Group Co., Ltd. (Stock code: 1167) has scheduled a board meeting on Tuesday, March 10, 2026. The primary agenda is to review and approve the annual results for the fiscal year ended December 31, 2025, along with other general business matters.

According to the announcement dated February 26, 2026, the board is led by Chairman and Executive Director, Dr. Yinxiang Wang, with additional executive, non-executive, and independent non-executive directors supporting the meeting to ensure comprehensive decision-making.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10